Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion wasGeneratedBy ECO_0000203 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion wasDerivedFrom befree-20140225 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion SIO_000772 21830945 NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion evidence source_evidence_literature NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_assertion description "[Intravitreal ranibizumab, which neutralizes vascular endothelial growth factor (VEGF), nowadays constitutes the first-line treatment in neovascular age-related macular degeneration (AMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP405246.RAIlq4bxJsnJaXkJFOsmk-kGsj100P_40-q6pDeM3Xcy0130_provenance.